Post-marketing surveillance of thrombomodulin alfa, a novel treatment of disseminated intravascular coagulation - safety and efficacy in 1,032 patients with hematologic malignancy.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Thrombomodulin alfa (Primary)
- Indications Disseminated intravascular coagulation
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record